Wright Medical Odyssey
This article was originally published in The Gray Sheet
Tissue-preserving minimally-invasive surgery program for hip, knee and total joint resurfacing procedures debuts initially for use with the firm's Profemur hip system, which gained expanded 510(k) clearance in July. Separately, the firm plans a limited October launch of its Micronail wrist fracture repair device following 510(k) clearance, announced Aug. 17. A full launch will follow in January. The fixed-angle locking screw implant targets 300,000 annual U.S. wrist fractures traditionally treated with casts and allows wrist use within a week of surgery...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.